We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
2951
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$8K ﹤0.01%
485
MBII
2952
DELISTED
Marrone Bio Innovations, Inc.
MBII
$8K ﹤0.01%
4,928
PLM
2953
DELISTED
PolyMet Mining Corp.
PLM
$8K ﹤0.01%
+2,264
New +$7.12K
BLES icon
2954
Inspire Global Hope ETF
BLES
$165M
$7K ﹤0.01%
190
+1
+0.5% +$39
HQI icon
2955
HireQuest
HQI
$231M
$7K ﹤0.01%
+399
New +$7.68K
ISMD icon
2956
Inspire Small/Mid Cap Impact ETF
ISMD
$347M
$7K ﹤0.01%
203
KRT icon
2957
Karat Packaging
KRT
$962M
$7K ﹤0.01%
+359
New +$6.82K
SLYV icon
2958
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.12B
$7K ﹤0.01%
85
SPAB icon
2959
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.95B
$7K ﹤0.01%
242
+26
+12% +$776
SPRB
2960
Spruce Biosciences
SPRB
$135M
$7K ﹤0.01%
8
SGTX
2961
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$7K ﹤0.01%
48
STON
2962
DELISTED
StoneMor Inc.
STON
$7K ﹤0.01%
+2,522
New +$5.74K
IEME
2963
DELISTED
iShares Evolved U.S. Media and Entertainment ETF
IEME
$7K ﹤0.01%
197
KLDO
2964
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$7K ﹤0.01%
995
REV
2965
DELISTED
Revlon, Inc.
REV
$7K ﹤0.01%
576
AVTX icon
2966
Avalo Therapeutics
AVTX
$1.05B
$6K ﹤0.01%
1
CRBN icon
2967
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.19B
$6K ﹤0.01%
40
EDV icon
2968
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
$6K ﹤0.01%
47
ELTX icon
2969
Elicio Therapeutics
ELTX
$82.7M
$6K ﹤0.01%
47
HYMB icon
2970
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.37B
$6K ﹤0.01%
230
LEGH icon
2971
Legacy Housing
LEGH
$683M
$6K ﹤0.01%
380
RQI icon
2972
Cohen & Steers Quality Income Realty Fund
RQI
$1.66B
$6K ﹤0.01%
394
+31
+9% +$469
FTH
2973
Faeth Therapeutics
FTH
$759M
$6K ﹤0.01%
31
SPYM
2974
State Street SPDR Portfolio S&P 500 ETF
SPYM
$170B
$6K ﹤0.01%
123
+10
+9% +$491
TPHD icon
2975
Timothy Plan High Dividend Stock ETF
TPHD
$371M
$6K ﹤0.01%
218
+2
+0.9% +$60

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.